University of Galway has announced two partnerships with leading Chinese medical universities. 

 The collaborations with Hebei Medical University and Xiangya School of Medicine, Central South University focus on stem cell research and PhD study opportunities.   

 The announcements were made as part of a trade mission to China led by An Taoiseach Micheál Martin T.D., with the support of Enterprise Ireland.  

 President of University of Galway, Professor David Burn, said: “University of Galway has developed strong links in China thanks to the excellence of our academic research. We are now seizing the opportunity to build on this and fulfil the promise set out in our Strategy 2025-2030 Of Galway, For the World, and we look forward to the impact that these partnerships can create for society and for healthcare.” 

 Professor Tim O’Brien, Director of the Regenerative Medicine Institute (REMEDI) at University of Galway, said: “By combining the strengths in regenerative medicine and clinical research at University of Galway with China’s scale, expertise and commitment to innovation, we are hopeful that these partnerships will deliver real benefit for patients and society. The relationships that we have built with these universities in China is international collaboration at its best: forward-looking, people-centred, and focused on shared global impact.” 

 The transnational education event in Beijing was attended by more than 150 people from 13 higher education institutions in Ireland and China. 

 University of Galway has renewed a partnership for a Joint Stem Cell Research Centre with Hebei Medical University. The collaboration will enable joint PhD and Masters supervision and collaborative research, including 12 postgraduate opportunities for students Hebei Medical University to enrol in the M.Sc. in Regenerative Medicine & M.Sc. in Cellular Manufacturing and Therapy in University of Galway. The partnership will also seek to drive collaborations between hospitals, universities, and industry in China and Ireland, bringing innovative regenerative stem cell therapies to patients worldwide. 

 A PhD scholarship Programme is also being renewed with the Chinese Scholarship Council (CSC) which funds up to 10 students from Xiangya School of Medicine to pursue PhD studies in Galway. The collaboration aims to strengthen joint clinical and scientific research between the EU and China, promote academic exchange and deepen institutional links.  

 Ends